【24h】

Real-time PCR strategy and detection of bacterial agents of lymphadenitis.

机译:实时PCR策略和淋巴结炎细菌因子的检测。

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of this study was to compare 16 S rRNA gene amplification and sequencing with a systematic real-time PCR assay screening strategy that includes all common known pathogens recovered from lymph node biopsy specimens. Lymph node biopsy samples sent to our laboratory from January 2007 to December 2008 were tested in the study. Lymph nodes were screened for the presence of any bacteria by PCR amplification and sequencing targeting the 16 S rRNA gene and also by a specific real-time PCR strategy that includes Bartonella henselae, mycobacteria, Francisella tularensis, and Tropheryma whipplei. By testing 491 lymph nodes, we found that the sensitivity of our specific real-time PCR assay strategy was significantly higher than 16 S rRNA PCR amplification and sequencing for the detection of Bartonella henselae (142 vs 98; p < 10(-4)), Francisella tularensis (16 vs 10, p < 10(-4)), and mycobacteria (8 versus 3, p < 10(-4)). None of the samples was positive for Tropheryma whipplei. Our study demonstrates the usefulness and specificity of a systematic real-time PCR strategy for molecular analysis of lymph node biopsy specimens and the higher sensitivity compared with standard 16 S rRNA gene amplification and sequencing.
机译:这项研究的目的是比较16 S rRNA基因扩增和测序与系统的实时PCR分析筛选策略,该策略包括从淋巴结活检标本中回收的所有常见已知病原体。在研究中对2007年1月至2008年12月送往我们实验室的淋巴结活检样本进行了测试。通过针对16 S rRNA基因的PCR扩增和测序,以及包括亨氏巴尔通体,分枝杆菌,土拉弗朗西斯菌和鞭毛壶菌的特定实时PCR策略,筛选淋巴结中是否存在细菌。通过测试491个淋巴结,我们发现我们特定的实时PCR分析策略的灵敏度显着高于16 S rRNA PCR扩增和测序,用于检测汉氏巴尔通体(142 vs 98; p <10(-4)) ,土拉弗朗西斯菌(16 vs 10,p <10(-4))和分枝杆菌(8 vs 3,p <10(-4))。所有样品均未检测到惠氏麻风杆菌。我们的研究表明系统实时荧光定量PCR方法对淋巴结活检标本的分子分析具有实用性和特异性,并且与标准16 S rRNA基因扩增和测序相比具有更高的灵敏度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号